Edition:
United Kingdom

TG Therapeutics Inc (TGTX.OQ)

TGTX.OQ on NASDAQ Stock Exchange Capital Market

7.00USD
21 May 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$7.00
Open
$6.79
Day's High
$7.00
Day's Low
$6.76
Volume
378,223
Avg. Vol
539,768
52-wk High
$15.95
52-wk Low
$3.41

About

TG Therapeutics, Inc. (TG) is a biopharmaceutical company focused on the acquisition, development and commercialization of treatments for B-cell malignancies and autoimmune diseases. As of December 31, 2016, the Company was developing two therapies targeting hematological malignancies. TG-1101 (ublituximab) is a glycoengineered... (more)

Overall

Beta: 1.34
Market Cap(Mil.): $846.68
Shares Outstanding(Mil.): 68.84
Dividend: --
Yield (%): --

Financials

  TGTX.OQ Industry Sector
P/E (TTM): -- 69.30 32.55
EPS (TTM): -1.95 -- --
ROI: -129.83 8.91 13.82
ROE: -133.51 10.05 15.24

Earnings vs. Estimates